Facebook Pixel Code

Phaarmasia Share Price

NSE
BSE

PHAARMASIA

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Phaarmasia along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹38.50 Closed
1.85₹ 0.7
As on Sep 16, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Phaarmasia Price Performance

Today's LowToday's High
₹35.92₹39.50
₹38.50
52 Weeks' Low52 Weeks' High
₹23.60₹64.53
₹38.50
Open Price
₹39.50
Prev. Close
₹37.80
Volume
393

Over the last 5 years, the share price of Phaarmasia has gained 6.96% CAGR. Over the past year, the corresponding return has been -39.84%.

Phaarmasia’s current P/E of -16.47x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Phaarmasia Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Phaarmasia
15.0638.8916.6320.80-39.8414.276.96
Sun Pharmaceutical Industries
0.99-1.32-4.43-5.58-13.5322.8625.44
Divi's Laboratories
1.35-1.39-9.097.2610.9819.3813.39
Cipla
0.28-0.531.924.23-6.2414.1815.63
Torrent Pharmaceuticals
-2.95-3.257.8115.502.3833.7519.96
Dr. Reddy's Laboratories
1.283.65-2.7313.87-1.4817.077.18
Mankind Pharma
-0.833.978.4518.234.5521.7212.52
Zydus Lifesciences
-0.294.776.1215.71-7.3542.0521.62
Lupin
4.714.152.023.02-8.9348.0414.81
Abbott India
1.23-4.93-2.022.816.4420.9013.41
Alkem Laboratories
3.353.0213.2114.40-13.3320.0114.29
Aurobindo Pharma
4.590.18-4.54-1.88-30.1026.955.60
Glenmark Pharmaceuticals
-1.885.1723.4145.1219.2277.3132.95
Laurus Labs
-0.753.4831.7154.0177.4820.1227.15
Biocon
-1.28-1.150.767.82-7.877.34-3.86
Anthem Biosciences
2.214.5314.6014.6014.604.652.76
GlaxoSmithKline Pharmaceuticals
-2.60-1.60-18.461.95-3.0024.239.16
Cohance Lifesciences
-2.9010.08-0.45-12.87-15.5428.9621.52
Ipca Laboratories
-0.61-5.32-3.76-0.34-10.1514.973.52
Gland Pharma
5.032.2413.9529.798.06-4.202.06

Over the last one year, Phaarmasia has declined 39.84% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Phaarmasia has underperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).

Phaarmasia Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Phaarmasia Stock Technicals

Moving Average

DaySMAEMA
533.6134.75
1033.1533.64
2030.9532.55
5032.431.99
10031.0832.82
20036.9835.47

Phaarmasia Share Holding Pattern

In the latest quarter, Phaarmasia remained same as its previous close in promoter holding, while DII stake unchanged at 0.05%, FII holding unchanged at 0.00%, and public shareholding moved down to 26.42% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Phaarmasia Corporate Actions

Date Time
Announcement
Sep 11, 2025, 3:28 AM ISTPhaarmasia Ltd. - Announcement under Regulation 30 (LODR)-Restructuring
Sep 03, 2025, 7:44 PM ISTPhaarmasia Ltd. - Intimation Of 44Th Annual General Meeting Of Phaarmasia Limited And Remote E-Voting.
Sep 03, 2025, 7:37 PM ISTPhaarmasia Ltd. - Reg. 34 (1) Annual Report.
Aug 13, 2025, 6:23 AM ISTPhaarmasia Ltd. - Integrated Filing (Financials) For The Quarter Ended 30Th June, 2025
Aug 11, 2025, 10:33 PM ISTPhaarmasia Ltd. - Financial Results For The Quarter Ended 30Th June 2025 - Regulation 33(3) (A) Of SEBI (LODR) Regulations, 2

About Phaarmasia

Phaarmasia Ltd. is a Public Limited Listed company incorporated on 06/02/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1981PLC002915 and registration number is 002915. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 24.37 Cr. and Equity Capital is Rs. 6.83 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Maneesh Ramakant Sapte
    Non Executive Director
  • Mr. Naga Bhaskara Rao Yallapragada
    Whole Time Director
  • Mr. Vinay Ramakant Sapte
    Non Executive Director
  • Mrs. Rashmi Vinay Sapte
    Non Executive Director
  • Mr. Pravin Mohandas Hegde
    Independent Director
  • Mr. Ajit Gopal Jamkhandikar
    Independent Director

FAQs on Phaarmasia Share Price

What is the share price of Phaarmasia?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Phaarmasia is ₹38.50 as on Sep 16, 2025.

What kind of stock is Phaarmasia?

The Phaarmasia is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Phaarmasia?

The market cap of Phaarmasia is ₹26.28 Cr as on Sep 16, 2025.

What are today's High and Low prices of Phaarmasia?

Today’s highest and lowest price of Phaarmasia are ₹39.50 and ₹35.92.

What are the 52 Week High and 52 Week Low of Phaarmasia?

The 52-week high/low is the highest and lowest price at which Phaarmasia stock has traded in the past 52-week or nearly a year. The 52-week high of Phaarmasia is ₹64.53 and 52-week low of Phaarmasia is ₹23.60 as on Sep 16, 2025.

How has the Phaarmasia performed historically in terms of returns?

The Phaarmasia has shown returns of 1.85% over the past day, 38.89% for the past month, 16.63% over 3 months, -39.84% over 1 year, 14.27% across 3 years, and 6.96% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Phaarmasia?

P/E ratio of and PB ratio of Phaarmasia are -16.47 and 3.01 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.

icon
Market Data